In addition to declining sales, BioNTech reported an €807.8 million net loss, which represents a widening from the €190.4 million net loss reported this time last year.
Stagwell smashes new business records as costs rise in Q2
The company saw a 37% decrease in net product sales totalling $184 million. They largely attributed this to shifts in the COVID-19 vaccine market, as that is their only product.
Takeda’s core operating profit grows 4.5%, outlook maintained
Takeda announced it would undergo a $900 million restructuring effort amid plummeting profit, but it’s banking on its growth and launch portfolio to give it a boost.
Teva’s generics business drives revenue growth to $4.2B
In the U.S. the company reported a 12% increase in sales totalling $2.1 billion while in Europe they saw a 4% increase totalling $1.2 billion in total revenues.
